Exagen Operating Cash Flow 2011-2026 | XGN

Annual Operating Cash Flow Exagen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-13.6 M	-13.3 M	-14.5 M	-32.1 M	-20.3 M	-14.1 M	-9.71 M	-9.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-9.3 M	-32.1 M	-15.9 M

Quarterly Operating Cash Flow Exagen

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-10.4 M	-	-	-10.7 M	-	-	-	-9.04 M	-	-	-	-9.75 M	-	-26.4 M	-	-8.57 M	-	-14.2 M	-	-4.31 M	-	-10.2 M	-8.06 M	-3.3 M	-	-5.78 M	-4.12 M	-1.95 M	-	-7.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-1.95 M	-26.4 M	-8.95 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Castle Biosciences CSTL	64.3 M	$ 20.03	4.32 %	$ 581 M	USA
Fulgent Genetics FLGT	21.1 M	$ 16.41	2.88 %	$ 496 M	USA
Guardant Health GH	-185 M	$ 114.97	17.09 %	$ 14.4 B	USA
ICON Public Limited Company ICLR	1.29 B	$ 115.09	1.36 %	$ 9.49 B	Irlanda
Interpace Biosciences IDXG	5.83 M	$ 1.8	-	$ 7.96 M	USA
Agilent Technologies A	1.48 B	$ 113.78	2.96 %	$ 34.6 B	USA
Illumina ILMN	837 M	$ 141.92	0.17 %	$ 22.6 B	USA
Celcuity CELC	-153 M	$ 140.34	7.16 %	$ 6.56 B	USA
Co-Diagnostics CODX	-29.1 M	$ 2.39	21.32 %	$ 3.18 M	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	42 M	$ 21.15	3.02 %	$ 1.13 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	390 M	$ 96.09	3.44 %	$ 6.49 B	USA
Medpace Holdings MEDP	713 M	$ 421.87	0.47 %	$ 12.2 B	USA
Mettler-Toledo International MTD	956 M	$ 1 082.67	3.04 %	$ 22.3 B	Schweiz
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
National Research Corporation NRC	26.4 M	$ 19.26	2.72 %	$ 431 M	USA
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Natera NTRA	-432 M	$ 204.92	4.53 %	$ 20.2 B	USA
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Personalis PSNL	-74.9 M	$ 7.95	12.93 %	$ 709 M	USA
Charles River Laboratories International CRL	738 M	$ 156.03	2.36 %	$ 7.73 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	5.23 M	$ 8.9	6.08 %	$ 1.14 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	1.8 M	$ 3.81	7.32 %	$ 353 M	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 451.79	0.89 %	$ 170 B	USA
Senseonics Holdings SENS	-59.1 M	$ 5.71	3.07 %	$ 238 M	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 53.66	8.4 %	$ 3.21 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Biomerica BMRA	-3.84 M	$ 2.35	-1.26 %	$ 5.4 M	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.6	6.95 %	$ 216 M	Irlanda
Laboratory Corporation of America Holdings LH	1.64 B	$ 257.42	1.47 %	$ 21.4 B	USA
Waters Corporation WAT	653 M	$ 341.32	2.42 %	$ 20.3 B	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 8.83	5.75 %	$ 1.92 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 193.75	1.92 %	$ 21.5 B	USA